Explore 3 Stock Ideas & Industry Insights Download Free Report

News

TPG Inc. CFO Receives RSU and PSU Grant in August 2026

TPG Inc. Chief Financial Officer Axel Andre received grants of 164,908 restricted stock units and 164,908 performance stock units on August 17, 2026, according to a Form 4 filed with the SEC on August 19, 2026.

Aditi Sarkar | 19 August 2026

Grab Holdings CFO Sells 50,000 Class A Shares

Peter Henry Oey, Chief Financial Officer of Grab Holdings Ltd, filed a Form 4 on August 19, 2026, disclosing the sale of 50,000 Class A Ordinary Shares on August 17, 2026, pursuant to a pre-established Rule 10b5-1(c) trading plan.

Manish Choudhary | 19 August 2026

Employers Holdings Principal Accounting Officer Reports Share Disposal

Matthew Robert Pollak, Principal Accounting Officer of Employers Holdings, Inc. (NYSE:EIG), filed a statement of changes in beneficial ownership on August 19, 2026, reporting a transaction dated August 17, 2026.

Aakashdeep | 19 August 2026

Forestar Group Director Sells 3,000 Shares of Common Stock

A beneficial ownership change report for Forestar Group Inc. was filed on August 19, 2026, disclosing a sale of common stock by director Lisa H. Jamieson on August 18, 2026.

Manish Choudhary | 19 August 2026

Teva Pharmaceutical EVP Sells 18,600 Ordinary Shares

Evan Lippman, Executive Vice President of Business Development at Teva Pharmaceutical Industries Ltd., filed a Form 4 on August 19, 2026, reporting the sale of 18,600 ordinary shares on August 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Anjali Anand | 19 August 2026

Riskified Director Sells Shares Under 10b5-1 Plan

A Form 4 filed on August 19, 2026 disclosed that Shachar Erez, a director of Riskified Ltd. (NYSE:RSKD), reported the sale of Class A Ordinary Shares on August 17 and August 18, 2026, conducted pursuant to a Rule 10b5-1 trading plan.

Manish Choudhary | 19 August 2026

Technical Analysis on One NYSE-Listed Pharmaceutical Stock: Merck & Co., Inc. (NYSE: MRK)

Merck & Co. is one of the largest global pharmaceutical companies, with a diversified portfolio spanning oncology, vaccines, and other therapeutic areas. As a large-cap pharma name, MRK's price action tends to be driven by a mix of steady fundamental developments — drug approvals, …

Vinay Lochav | 19 August 2026

Maravai LifeSciences Holdings (NASDAQ: MRVI): A Technical Read on the NASDAQ-Listed Life Sciences Tools Stock

Maravai LifeSciences Holdings is a life sciences company providing critical products used in nucleic acid production andBiologicssafety testing, including reagents and technologies that support mRNA-basedVaccineand therapeutic development. As a tools and reagents supplier rather than a clinical-stage drug developer, MRVI's price action tends to …

Vinay Lochav | 19 August 2026

Technical Analysis on One NASDAQ-Listed Clinical-Stage Biotech Stock: Sana Biotechnology, Inc. (NASDAQ: SANA)

Key TakeawaysSana Biotechnology surged 12.95% (+$0.47) on Thursday to close at $4.10, breaking out decisively above both its 21-day EMA ($3.56) and 63-day EMA ($3.43) after months of trading below these key trend lines.The rally came onVolumeof 5.9 million shares, a sharp pickup versus …

Vinay Lochav | 19 August 2026

Technical Analysis on One NASDAQ-Listed Biopharmaceutical Stock: BioNTech SE (NASDAQ: BNTX)

BioNTech SE is a German biopharmaceutical company best known for its mRNA-basedVaccineand therapeutic platform, with an expanding pipeline spanning oncology, infectious disease, and other areas beyond its original COVID-19 vaccineFranchisedeveloped with Pfizer. As with many biopharma names of its scale, BNTX's share price has …

Vinay Lochav | 19 August 2026
Support

Hi! How can we help you today?

Loading…